Clinical Trial Update: Hyperglycemia and Effects of Daily 100 mg Versus 200 mg of Hydrocortisone Therapy in Patients With Septic Shock [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing daily hydrocortisone doses (100 mg vs 200 mg) in septic shock and its association with hyperglycemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperglycemia
• Septic Shock

Drugs mentioned

• HYDROCORTISONE (HYDROCORTISONE)

Snippet

Sponsor: Srinakharinwirot University | Conditions: Hyperglycemia | Phase 4 | Status: COMPLETED